Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals.
Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Company Financials:
| Particulars | For the year/period ended (₹ in million) | ||||
|---|---|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |||
| Total Assets | 3,148.03 | 2,489.38 | 1,875.08 | ||
| Total Revenue | 3,062.92 | 2,646.22 | 2,068.01 | ||
| Profit After Tax | 522.62 | 377.89 | 205.43 | ||
Objects of the Issue:
- Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
- Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
- To meet general corporate purposes.
Tatva Chintan Pharma IPO Subscription Status (Bidding Detail)
The Tatva Chintan Pharma IPO is subscribed 15.75x times as at the time of releasing this post. The public issue subscribed 24.27x in the retail category, 1.97x in the QIB category, and 14.24x in the NII category.
| Category | IPO Subscription |
|---|---|
| QIB | 1.97x |
| NII | 14.24x |
| RII | 24.27x |
| Total | 15.75x |
Today is the last day to apply for this IPO and you can apply to this IPO using your ASBA account provided by your bank or using the services provided by your brokers such as Upstox, Zerodha or such other brokers.
Now, one might think that why is this IPO so much over subscribed? Is it that good?
The answer to same is Yes as well as No.
The IPO is good because as on date the specialty chemical sector is on a boom and the objects for which the IPO has been brought is also great i.e. expansion of it’s capacity which will in turn increase production and probably profit as well.
However, this is not the only reason as to why this IPO is so much over subscribed. As we know right now in India there is a rain of IPO’s and hence people are investing heavily in IPO’s and this being a comparatively small IPO of around Rs. 500 crore people have hugely subscribed the same and hence it is looking so much over-subscribed.
Capital gain tax on sale of shares received in IPO allotment:
Now, let’s talk about the taxability of gain earned if the shares are sold on the listing date itself to get listing gain by way of premium on listing and if the same is sold after some time.
You can book phone consultation/ assistance online with expert as mentioned below:
To book ITR filing with experts CLICK ME.
To book phone consultation with experts for Income tax CLICK ME.
To book consultation for Faceless Assessment with experts CLICK ME.
To book phone consultation with experts for GST CLICK ME.
To book general phone consultation with expert CLICK ME.
